Discovery and validation of circulating stroke metabolites by NMR-based analyses using patients from the MISS and UK Biobank
Neurochemistry International · 2023-10 · 169 · 105588
DOI: 10.1016/j.neuint.2023.105588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemistry International, 2023-10. Verfasst von Madhusmita Rout und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. Hauptthemen laut MEDLINE: Stroke, Ischemic Stroke. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: NIDDK NIH HHS.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Stroke is a significant health issue in the United States, and identifying biomarkers for the prevention and functional recovery after an acute stroke remains the highest priority. This study aims to identify circulating metabolite signatures that may be associated with stroke pathophysiology by performing discovery and validation studies. METHODS: We performed targeted metabolomics profiling of 420 participants of the discovery dataset of Metabolome in an Ischemic Stroke Study (MISS) using high-throughput nuclear magnetic resonance (NMR) spectroscopy. A validation study of significantly altered metabolites was conducted using an independent cohort of 117,988 participants from the UK Biobank, whose metabolomics profiles were generated using the same NMR technology. RESULTS AND CONCLUSION: Our study identified 16 metabolites to be significantly perturbed during acute stroke. Amino acid phenylalanine was significantly increased, while glutamine and histidine were significantly lowered in stroke. Serum levels of apolipoprotein A-1, HDL particles, small HDL particles, essential fatty acids, and phosphatidylcholine were reduced, while ketone bodies like 3-hydroxybutyrate and acetoacetate were markedly increased in stroke. Based on the robust validation in a large independent UK Biobank dataset, some of these analytes may become clinically meaningful biomarkers to predict or prevent stroke in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
- Department of Neurology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
- Department of Cardiology, Oklahoma University of Health Sciences Center, Oklahoma City, OK, USA.
- Department of Pediatrics, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma…
Förderung
- NIDDK NIH HHS
Zitieren
APA
Rout, M., Vaughan, A., Blair, A., Stavrakis, S., Sidorov, E. V., & Sanghera, D. K. (2023). Discovery and validation of circulating stroke metabolites by NMR-based analyses using patients from the MISS and UK Biobank. Neurochemistry International, 169, 105588. https://doi.org/10.1016/j.neuint.2023.105588
Vancouver
Rout M, Vaughan A, Blair A, Stavrakis S, Sidorov EV, Sanghera DK. Discovery and validation of circulating stroke metabolites by NMR-based analyses using patients from the MISS and UK Biobank. Neurochemistry International. 2023;169:105588. doi:10.1016/j.neuint.2023.105588
BibTeX
@article{Rout2023,
author = {Rout, Madhusmita and Vaughan, April and Blair, Apple and Stavrakis, Stavros and Sidorov, Evgeny V and Sanghera, Dharambir K},
title = {Discovery and validation of circulating stroke metabolites by NMR-based analyses using patients from the MISS and UK Biobank},
journal = {Neurochemistry International},
year = {2023},
volume = {169},
pages = {105588},
doi = {10.1016/j.neuint.2023.105588}
}
EUVIMED